Altoida, a developer of AI and augmented reality-
Author: Michael
Ultrahuman and Click Therapeutics have formed a s
AliveCor Inc. announced that the U.S.
dōTERRA International, LLC, a global leader in e
New research suggests Junevity’s siRNA approac
With its immune-restoring TRIIM platform in the
Coya’s FDA clearance for COYA 302 opens new ch
Health Canada approves Rybelsus, the first oral
A new imaging-drug collaboration aims to show wh
The global atherosclerotic cardiovascular disease